Figures computed from official regulatory filings — .
Statistical track record
Free accountWin rates, median returns and the proven-insider analysis come with a free account.
Create a free accountThis page republishes public regulatory disclosures.
| Company | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
ORAMED PHARMACEUTICALS INC.Listing on record | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC | ||
ORAMED PHARMACEUTICALS INC.Listing on record | Other | $1.1M | SEC | ||
ORAMED PHARMACEUTICALS INC.Listing on record | BuyD (derivative) | $502.6 | SEC | ||
ORAMED PHARMACEUTICALS INC.Listing on record | BuyD (derivative) | $2.1K | First in 12mo | SEC | |
ORAMED PHARMACEUTICALS INC.Listing on record | BuyD (derivative) | $1.8K | SEC | ||
ORAMED PHARMACEUTICALS INC.Listing on record | Other | $664.4 | SEC | ||
ORAMED PHARMACEUTICALS INC.Listing on record | Other | $2.9K | SEC | ||
ORAMED PHARMACEUTICALS INC.Listing on record | Buy | $49.1K | conv 20 | SEC | |
LEGEND INTERNATIONAL HOLDINGS INCListing unverified | Buy | $2.3M | conv 47 | SEC | |
ORAMED PHARMACEUTICALS INC.Listing on record | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC | ||
ORAMED PHARMACEUTICALS INC.Listing on record | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC | ||
ORAMED PHARMACEUTICALS INC.Listing on record | BuyD (derivative) | n/a (No price was disclosed in the filing) | SEC | ||
ORAMED PHARMACEUTICALS INC.Listing on record | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC | ||
ORAMED PHARMACEUTICALS INC.Listing on record | BuyD (derivative) | n/a (No price was disclosed in the filing) | SEC | ||
ORAMED PHARMACEUTICALS INC.Listing on record | BuyD (derivative) | n/a (No price was disclosed in the filing) | SEC | ||
ORAMED PHARMACEUTICALS INC.Listing on record | BuyD (derivative) | n/a (No price was disclosed in the filing) | SEC | ||
LEGEND INTERNATIONAL HOLDINGS INCListing unverified | Buy | $2.3M | conv 63First in 12mo | SEC |